 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Kiniksa Pharmaceuticals Ltd. (KNSA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-06 Sale | 2020-03-10 5:33 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 33,115 | $20 | $662,300 | 212,570 (Indirect) | View |
| 2020-04-20 Sale | 2020-04-22 5:39 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 49,941 | $19.1 | $953,975 | 29,589 (Direct) | View |
| 2020-06-10 Sale | 2020-06-12 5:50 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 13,752 | $25.07 | $344,763 | 29,589 (Direct) | View |
| 2020-07-01 Sale | 2020-07-02 4:13 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 29,589 | $25.37 | $750,678 | 0 (Direct) | View |
| 2020-10-09 Sale | 2020-10-14 5:22 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 251,572 | $21.02 | $5,288,013 | 112,570 (Indirect Direct) | View |
| 2021-02-03 Sale | 2021-02-05 6:55 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 2,477 | $22.09 | $54,717 | 297,523 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 7:07 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 56,159 | $23.05 | $1,294,534 | 83,336 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-27 Exercise | 2020-03-02 5:48 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 12,000 | $1.86 | 30,000 (Direct) | View |
| 2020-02-27 Exercise | 2020-03-02 5:48 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 12,000 | $0 | 197,574 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:21 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:22 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:22 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:23 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 5:23 pm | N/A 2030-03-12 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 180,000 | $0 | 180,000 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-18 6:57 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 134,397 | $18.25 | 1,050,440 (Indirect) | View |
| 2020-05-18 Option Award | 2020-05-18 6:57 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 1,465,603 | $18.25 | 10,302,952 (Indirect) | View |
| 2020-06-10 Exercise | 2020-06-12 5:50 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 13,752 | $1.59 | 43,341 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:50 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 13,752 | $0 | 112,189 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:11 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 18,760 | $0 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:11 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 18,760 | $0 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:12 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 18,760 | $0 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:12 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 18,760 | $0 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:14 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 18,760 | $0 | 18,760 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 5:53 pm | N/A 2030-06-30 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 37,520 | $0 | 37,520 (Indirect) | View |
| 2020-07-24 Option Award | 2020-07-28 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 93,210 | $21 | 1,143,650 (Indirect) | View |
| 2020-07-24 Option Award | 2020-07-28 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 1,335,362 | $21 | 11,638,314 (Indirect) | View |
| 2020-07-27 Option Award | 2020-07-29 5:46 pm | N/A 2030-07-26 | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 37,965 | $0 | 37,965 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:06 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 19,000 | $0 | 19,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:09 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:12 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:14 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:16 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 180,000 | $0 | 180,000 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 872 | $1.59 | 872 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 150,700 | $1.59 | 150,700 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 872 | $0 | 502,896 (Direct) | View |
| 2020-10-09 Exercise | 2020-10-14 5:22 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 150,700 | $0 | 352,196 (Direct) | View |
| 2020-12-31 Exercise | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 7,337 | $0 | 7,337 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 2,161 | $17.67 | 5,176 (Direct) | View |
| 2020-12-31 Exercise | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer | 7,337 | $0 | 0 (Direct) | View |
| 2020-12-31 Exercise | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 4,404 | $0 | 4,404 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 1,297 | $17.67 | 3,107 (Direct) | View |
| 2020-12-31 Exercise | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 4,404 | $0 | 0 (Direct) | View |
| 2021-02-03 Conversion | 2021-02-05 6:55 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-02-03 Conversion | 2021-02-05 6:55 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 300,000 | $0 | 114,157 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 4,924 | $1.59 | 4,924 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 20,401 | $1.59 | 20,401 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 1,600 | $1.59 | 1,600 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:07 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 4,924 | $0 | 347,272 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:07 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 20,401 | $0 | 326,871 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:07 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 1,600 | $0 | 325,271 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:07 pm | N/A 2031-03-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 52,611 | $0 | 52,611 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 8,769 | $0 | 8,769 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:10 pm | N/A 2031-03-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 157,658 | $0 | 157,658 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:10 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 26,276 | $0 | 26,276 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:12 pm | N/A 2031-03-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 41,400 | $0 | 41,400 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:12 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 6,900 | $0 | 6,900 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:12 pm | N/A 2031-03-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 6,195 | $0 | 6,195 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:12 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 3,098 | $0 | 3,098 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:14 pm | N/A 2031-03-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 20,925 | $0 | 20,925 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:14 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 3,488 | $0 | 3,488 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 5,855 | $0 | 5,855 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 4,287 | $0 | 4,287 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:33 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 18,555 | $0 | 18,555 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:33 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CEO Chairman | 12,002 | $0 | 12,002 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:34 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 3,231 | $0 | 3,231 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:34 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CAO | 2,163 | $0 | 2,163 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 5,676 | $0 | 5,676 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer | 3,671 | $0 | 3,671 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 3,019 | $0 | 3,019 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 2,158 | $0 | 2,158 (Direct) | View |
| 2021-04-26 Option Award | 2021-04-28 5:31 pm | N/A 2031-04-25 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 23,725 | $0 | 23,725 (Direct) | View |
| 2021-04-26 Option Award | 2021-04-28 5:31 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 3,962 | $0 | 3,962 (Direct) | View |